Genovate Biotechnology Co., Ltd. (4130)
(Delisted)TWSE
26.70
0.00 (0.00%)
Closed
Jul 28, 2026
Day's Range
26.7026.70
52 wk Range
17.6538.89
Financial Statements - 4130 - Genovate Biotechnology Co., Ltd.
Revenue
492.40M▼ 3.6%
Net Income
11.68M▼ 54.5%Net Margin 2.4%
EBITDA
52.88M▼ 23.8%
Free Cash Flow
-17.62M▼ 174.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 492.40M | 510.85M | 528.51M | 438.75M | 434.25M | 472.72M |
| Cost of Goods | 315.38M | 318.20M | 317.59M | 283.88M | 284.50M | 279.61M |
| Gross Profit | 177.02M | 192.64M | 210.91M | 154.87M | 149.75M | 193.10M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 6.91M | 23.42M | 26.99M | -13.89M | -1.16M | 39.46M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 13.45M | 31.06M | 30.82M | -9M | 3.56M | 40.75M |
| Income Tax | 1.77M | 5.36M | 1.49M | 3.32M | 3.19M | 2.02M |
| Net Income | 11.68M | 25.69M | 29.33M | -12.32M | 372K | 38.73M |
| EPS Basic | 0.096851 | 0.21839 | 0.262136 | -0.106796 | 0.003348 | 0.349515 |
| EPS Diluted | 0.096851 | 0.21839 | 0.262136 | -0.106796 | 0.003346 | 0.349515 |
| Basic Shares Outstanding | 117.44M | 118.30M | 112.65M | 111.12M | 111.11M | 111.11M |
| Diluted Shares Outstanding | 117.44M | 118.30M | 112.65M | 111.12M | 111.11M | 111.11M |
| Ebit | 14.13M | 31.57M | 31.09M | -8.72M | 3.82M | 41M |
| Ebitda | 52.88M | 69.41M | 67.62M | 27.36M | 39.63M | 76.18M |
| Net Income Continuous Operations | 13.45M | 31.06M | 30.82M | -9M | 3.56M | 40.75M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
